Our results show that pasireotide, a multireceptor-targeted SA with high affinity for SSTR1, 2, 3, and 5 is effective in reducing proliferation and increasing apoptosis of pancreatic and pituitary NETs (Figures 5 and 6) that develop in a mouse model for MEN1. Here, MEN1 is linked to hypophysitis.